JPRN-UMIN000013970已完成未知
I-131 therapy for metastatic thyroid cancer with recombinant human thyroid-stimulating hormone (Thyrogen) - I-131 therapy for metastatic thyroid cancer with recombinant human thyroid-stimulating hormone
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) a patient whose thyroid Ca has not able to uptake I-131 2) a patient with clitical disease 3) a patient who was administered an iodinated contrast agent 4) pregnant female and feeding female 5) when medical staff determine that treatment can not be properly carried out
研究者
相似试验
已完成
不适用
I-131 therapy for thyroid cancer with recombinant human thyroid-stimulating hormone (Thyrogen)Thyroid cancerJPRN-UMIN000005692Kanazawa University Hospital1
进行中（未招募）
不适用
Study for metastatic thyroid cancer using 124i and [18F] FDG PET / CT in patients with elevated values of Tg and / or AbTg with negative ultrasonography of the neck, previously treated with thyroidectomy and radioiodine therapy. - I124Only patiensMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2010-023831-40-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
进行中（未招募）
1 期
Personalized therapy of metastatic thyroid cancer: biological characterization and optimization with 124I PET dosimetrymetastatic thyroid cancerMedDRA version: 20.0Level: PTClassification code 10076603Term: Poorly differentiated thyroid carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-002548-21-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI50
撤回
不适用
Fast-track thyroidectomy and I-131 radioiodine ablation therapy in patients with differentiated thyroid cancer.1004373910014713Thyroid cancerNL-OMON38352niversitair Medisch Centrum Utrecht70
进行中（未招募）
1 期
A Pilot Study in Metastatic Advanced Thyroid Cancer Evaluating the Safety and Efficacy of Sorafenib - MATiSSePatients with localled advanced or metastatic thyroid cancer . histological sub-types will include differentiated and medullary thyroid cancer.EUCTR2006-006615-80-GBRoyal Marsden Nhs Foundation Trust33